$SLS
SELLAS Life Sciences Group, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$13.79
▼-0.51%-$0.070
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSELLAS Life Sciences Group, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SLS down today? It is at $13.79 (-0.51%), and our scanner flagged it 335 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SLS spikes, and full due diligence on SLS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SLS 335 times in the last 30 days. Create a free account to track $SLS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
SLS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on SLS today.
Likely catalystSELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateReported - $138.3 Million in Cash and Cash Equivalents as of June 30, 2026 -Reported Cash Position: As of June 30, 2026, cash and cash equivalents totaled approximately $138.3 million.Reported Common stock, $0.0001 par value; 350,000,000 shares authorized, 201,918,874 and 153,103,459 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stergiou Angelos M. Officer | Acquired (grant/award) | +1.06M 0.5% of company | added 100% | 1.76M | n/a | Jun 16, 26 |
Wasman Jane Director | Acquired (grant/award) | +50K 0.02% of company | added 100% | 93K | n/a | Jan 7, 26 |
Kalin Katherine Bach Director | Acquired (grant/award) | +50K 0.02% of company | added 48% | 154K | n/a | Jan 7, 26 |
Burns John Thomas Officer | Acquired (grant/award) | +300K 0.1% of company | added 100% | 554K | n/a | Jan 7, 26 |
Cicic Dragan Officer | Acquired (grant/award) | +300K 0.1% of company | added 100% | 558K | n/a | Jan 7, 26 |
Scheinberg David A Director | Acquired (grant/award) | +50K 0.02% of company | added 100% | 73K | n/a | Jan 7, 26 |
Van Nostrand Robert L Director | Acquired (grant/award) | +50K 0.02% of company | added 100% | 83K | n/a | Jan 7, 26 |
Varian John Director | Acquired (grant/award) | +50K 0.02% of company | added 100% | 73K | n/a | Jan 7, 26 |
Stergiou Angelos M. Officer | Sold (automatic/other) | -187K 0.09% of company | sold 21% | 687K | $281K at $1.50 | Dec 3, 25 |
Burns John Thomas Officer | Sold (automatic/other) | -59K 0.03% of company | sold 19% | 254K | $88K at $1.50 | Dec 3, 25 |
Cicic Dragan Officer | Sold (automatic/other) | -64K 0.03% of company | sold 20% | 258K | $96K at $1.50 | Dec 3, 25 |
Kalin Katherine Bach Director | Bought (open market) | +63K 0.03% of company | added 100% | 104K | $101K at $1.59 | Nov 19, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
SLS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on SLS today.
SLS last traded at $13.79, down 0.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Yes. SLS currently has a dividend yield of about 6.94% ($0.96 per share per year). Dividend figures can change; this is not investment advice.
The SLS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SLS 335 times in the last 30 days.
SLS (SELLAS Life Sciences Group, Inc. Common Stock) trades on XNAS, with a market cap of about $2.80B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SLS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SLS discussion
Sign in to ask a question or join the discussion.